Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oshadi D and Oshadi R with Salvage Chemotherapy in R/R AML or ALL
NCT02462265Phase 2Suspended
- Sponsor
- Oshadi Drug Administration Ltd.
- Start
- Jan 2017
- Primary completion
- Jun 2018
- Modality
- Nanoparticles, Small Molecules, Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of Deoxyribonuclease in Oshadi carrier, oshadi r in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), sponsored by Oshadi Drug Administration Ltd.. Started Jan 2017; status: suspended.
02
Drugs
Deoxyribonuclease in Oshadi carrieroshadi r
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT02462265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02462265.